PMA device
PulseSelect Pulse Field Ablation (PFA) Catheter
Medtronic, Inc. · Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI, Class III) · First FDA decision Apr 13, 2026, newest Apr 13, 2026Atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
6
Naming "PulseSelect"
MAUDE reports
2,368
Brand "PulseSelect", since 2015
PubMed studies
84
Mentioning "PulseSelect"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing PulseSelect Pulse Field Ablation (PFA) Catheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- PulseSelect Pulse Field Ablation (PFA) CatheterPMA supplement
P230017-S010 · Decided Apr 13, 2026 · 34 days after receipt · Normal 180 Day Track No User Fee
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
- Irreversible Electroporation for CancerLocal determinationIn effectL40205Palmetto GBAUpdated May 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "PulseSelect", any status and sponsor, newest update first.
- PULSED AF Post-Approval StudyRecruiting
Medtronic Cardiac Ablation SolutionsPublic (MDT)
NCT06578104 · 580 participants (planned) · Start Nov 4, 2024 · Primary completion Apr 30, 2027
Device: PulseSelect™ PFA system · For: Atrial Fibrillation
Sites: Huntsville, Alabama; Clermont, Florida; Tampa, Florida · 29 sites in all
- Outcomes of an Optimized Workflow With PulseSelect Pulsed Field Ablation (PFA) System in Paroxysmal and Persistent Atrial FibrillationNot yet recruiting
Medtronic Cardiac Ablation SolutionsPublic (MDT)
NCT07575828 · 320 participants (planned) · Start Oct 2026 · Primary completion Aug 2028
Device: PulseSelect Pulse Field Ablation (PFA) System · For: Paroxysmal Atrial Fibrillation (PAF); Persistent Atrial Fibrillation
- Cerebral Microembolization During Pulmonary Vein Isolation: Comparison of Different Pulsed Field Ablation SystemsPivotal-lookingNot yet recruiting
Ivan ZeljkovicAcademic, hospital or other
NCT07610018 · 100 participants (planned) · Start Jun 1, 2026 · Primary completion Jan 1, 2027
Device: Pulsed field ablation using PulseSelect system; Pulsed field ablation using Varipulse system and 3 more · For: Ablation of Arrhythmia's
Sites: Zagreb, Croatia · 2 sites in all
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "PulseSelect", and for the whole product code for context.
This brand
2,368 reports: 1,518 malfunction, 827 injury, 21 death
Whole product code QZI
10,522 reports: 5,457 malfunction, 4,777 injury, 245 death
Newest reports for this brand
- PulseSelectInjury
3002648230-2026-01200 · Received Oct 29, 2026 · Event dated Oct 29, 2025
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Chest Pain; Heart Block; Gastrointestinal Regurgitation
- PulseSelectMalfunction
3002648230-2026-01199 · Received Oct 28, 2026 · Event dated Oct 1, 2026
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Material Deformation
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- PulseSelectMalfunction
3002648230-2026-01196 · Received Oct 27, 2026 · Event dated Jun 18, 2026
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Break; Material Deformation; Material Twisted/Bent
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "PulseSelect"[tiab]. The summary above synthesizes these.
- Pulsed Field Ablation-Related Hemolysis: Comparison Between Technologies.
Gianni C, Al-Ahmad A, Elchouemi M, et al. · Circ Arrhythm Electrophysiol · 2025Comparative Study
- Comparison of hemolysis with different pulsed field ablation systems.
Kawamura I, Miyazaki S, Kato R, et al. · Heart Rhythm · 2026Comparative Study
- Real-time detection of microembolic signals using carotid echocardiography: A comparative study of 3 pulsed-field systems.
Shiomi S, Tokuda M, Takato U, et al. · Heart Rhythm · 2026Comparative Study, Research Support, Non-U.S. Gov't
- PulseSelect vs FARAPULSE pulsed field ablation: Comparative analysis of myocardial, neural-injury and hemolysis biomarkers and short-term outcomes.
Gold C, Falagkari A, Post F, et al. · Int J Cardiol Heart Vasc · 2026
- Pulsed-Field Ablation-Induced Coronary Vasospasm for Atrial Tachycardia Originating From the Lateral Tricuspid Annulus.
Kouguchi T, Sagawa Y, Murata K, et al. · JACC Case Rep · 2025Case Reports
- Pulse Field Ablation for Persistent Atrial Fibrillation: Targeting the Persistent Superior Vena Cava.
Vázquez-Calvo S, Poletaev V, Verma A, et al. · Pacing Clin Electrophysiol · 2025Case Reports, Research Support, Non-U.S. Gov't
- Enhanced contact of the PulseSelect catheter using the contact index during pulmonary vein isolation.
Mizutani Y, Fujiwara G, Yanagisawa S, et al. · Heart Rhythm · 2026
- Near-Zero Fluoroscopy Ablation Workflow With a Circular Multielectrode Pulsed-Field Ablation Catheter.
Yamashita K, Kikuchi Y, Yoshiyama K, et al. · Pacing Clin Electrophysiol · 2025
- Real-world adverse events of pulsed field ablation for atrial fibrillation: A comprehensive analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience database.
Hammadeh BM, Aldib L, Challa A, et al. · Heart Rhythm · 2026
- Incidence of cough reflex and vagal response among various pulsed field ablation systems: a multicenter registry study.
Kawamura I, Miyazaki S, Nitta J, et al. · Clin Res Cardiol · 2025
- Differential subclinical hemolysis after pulsed field ablation using the FARAPULSE pentaspline catheter vs the PulseSelect circular multi-electrode array catheter.
Kuraoka S, Nozoe M, Mannoji H, et al. · Heart Rhythm O2 · 2025
- Incidence and Characteristics of Superior Vena Cava Impact After Pulsed-Field Ablation of the Right Pulmonary Veins.
Matsuura H, Kamakura T, Oshima T, et al. · J Cardiovasc Electrophysiol · 2025Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code QZI.
- FARAPULSE Pulsed Field Ablation System (FARAWAVE Pulsed Field Ablation CatheterFarapulse, Inc. · PMA 2026
- Volt PFA SystemAbbott Medical · PMA 2026
- VARIPULSE Catheter, TRUPULSE Generator with Connection Interface Unit (CIU)Biosense Webster, Inc. · PMA 2026
- Sphere-9 Catheter and Affera Ablation SystemMedtronic, Inc. · PMA 2026
- PulseSelect Pulsed Field Ablation (PFA) systemMedtronic, Inc. · PMA 2026
- Globe® Catheter and Globe® Pulsed Field SystemKardium, Inc. · PMA 2026
- FARASTAR Pulsed Field Ablation (PFA) GeneratorFarapulse, Inc. · PMA 2025
- Globe® Pulsed Field SystemKardium, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.